SCHEMBL7773141

SCHEMBL7773141

N#CCn1nc(-c2ccc(S(N)(=O)=O)cc2)c(-c2ccc(Cl)cc2)c1C(=O)Nc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK9 P45984 1/20 0.52
PTGS2 P35354 3/20 0.49
CA1 P00915 10/20 0.46
CA2 P00918 10/20 0.46
CA4 P22748 3/20 0.46
CA7 P43166 3/20 0.46
CA12 O43570 6/20 0.46
CA9 Q16790 6/20 0.46
LDHA P00338 2/20 0.46
LDHB P07195 2/20 0.46
MAPT P10636 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
KDR P35968 1/20 0.44
AURKA O14965 1/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
PSMD14 O00487 1/20 0.42
POLB P06746 1/20 0.42
RECQL P46063 1/20 0.42
CACNA1B Q00975 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7779899 0.91 PTGS2 (0.49) MAPK9PTGS2MAPTTDP1AURKA
SCHEMBL7778036 0.91 PTGS2 (0.49) MAPK9PTGS2CA1CA2CA4
SCHEMBL7779586 0.88 MAPK9 (0.54) MAPK9PTGS2CA1CA2CA4
SCHEMBL7780610 0.88 MAPK9 (0.54) MAPK9PTGS2CA1CA2CA4
SCHEMBL7778220 0.86 PTGS2 (0.47) PTGS2CA1CA2CA4CA12
SCHEMBL7779408 0.85 MAPK9 (0.52) MAPK9PTGS2CA1CA2CA4
SCHEMBL7777303 0.85 MAPK9 (0.52) MAPK9PTGS2CA1CA2CA4
SCHEMBL8173979 0.83 CA1 (0.53) PTGS2CA1CA2CA4CA12
SCHEMBL7779467 0.83 PTGS2 (0.45) PTGS2CA1CA2CA4CA7
SCHEMBL7779610 0.83 PTGS2 (0.50) PTGS2MAPTTDP1AURKAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5756530-A NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS G. D. SEARLE & CO. (US) 1998-05-26 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed